sfericase
Biologicalexperimental
Clinical trial activity
5 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 31, 2015 (NCT02588521)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2108114 ↗
Also known as
- al-794
- al-794
- sfericase
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05317078 | Phase 1 | Dec 31, 2022 | Amgen |
| NCT03411421 | Phase 1 | Mar 3, 2018 | Alios BioPharma, Hammersmith Medicines Research |
| NCT02888327 | Phase 1 | Jul 31, 2016 | Alios BioPharma, Hammersmith Medicines Research |
| NCT02877160 | Phase 1 | Jun 30, 2016 | Alios BioPharma |
| NCT02588521 | Phase 1 | Aug 31, 2015 | Alios BioPharma |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Alios BioPharma | For profit | 4 | 4 | 1 | 2015 |
| Hammersmith Medicines Research | For profit | 2 | 0 | 1 | 2016 |
| Amgen | For profit | 1 | 1 | 1 | 2022 |
3 organizations
Page 1 / 1